From: Pooling analysis regarding the impact of human vitamin D receptor variants on the odds of psoriasis
Models | M | I2 | P heterogeneity | Stratification | case/control (N) | OR [95% CI] | P association | BH |
---|---|---|---|---|---|---|---|---|
allele C vs. T | R | 47.5% | 0.034 | overall | 1690/1857 (12) | 0.91 [0.75~1.10] | 0.325 | 0.690 |
57.2% | 0.053 | Asian | 941/837 (5) | 0.91 [0.58~1.43] | 0.689 | 0.798 | ||
47.4% | 0.090 | Caucasian | 699/970 (6) | 0.87 [0.70~1.08] | 0.216 | 0.629 | ||
47.7% | 0.045 | PB | 1143/1436 (10) | 0.90 [0.73~1.12] | 0.341 | 0.524 | ||
49.7% | 0.137 | China | 776/682 (3) | 1.01 [0.62~1.64] | 0.962 | 0.974 | ||
73.1% | 0.024 | Turkey | 206/256 (3) | 0.93 [0.54~1.61] | 0.806 | 0.824 | ||
45.7% | 0.056 | PHWE > 0.05 | 1383/1675 (10) | 0.90[0.72~1.11] | 0.324 | 0.389 | ||
57.4% | 0.021 | PCR-RFLP | 806/907 (8) | 0.88 [0.68~1.14] | 0.360 | 0.744 | ||
CC vs. TT | F | 38.2% | 0.114 | overall | 1325/1508 (9) | 0.92[0.67~1.25] | 0.581 | 0.690 |
0.0% | 0.460 | Asian | 781/568 (3) | 0.80[0.24~2.66] | 0.717 | 0.798 | ||
58.7% | 0.046 | Caucasian | 494/890 (5) | 0.87 [0.62~1.22] | 0.419 | 0.629 | ||
43.7% | 0.087 | PB | 983/1167 (8) | 0.90 [0.66~1.24] | 0.524 | 0.524 | ||
73.8% | 0.022 | Turkey | 206/256 (3) | 1.05 [0.68~1.81] | 0.868 | 0.974 | ||
0.0% | 0.511 | China | 666/499 (2) | 1.24 [0.28~5.53] | 0.775 | 0.824 | ||
24.8% | 0.231 | PHWE > 0.05 | 1223/1406 (8) | 0.79[0.56~1.12] | 0.183 | 0.386 | ||
59.8% | 0.029 | PCR-RFLP | 551/741 (6) | 0.88 [0.61~1.28] | 0.499 | 0.749 | ||
TC vs. TT | R | 46.8% | 0.043 | overall | 1485/1777 (11) | 0.95[0.72~1.24] | 0.690 | 0.690 |
51.5% | 0.083 | Asian | 941/837 (5) | 0.90[0.58~1.42] | 0.658 | 0.798 | ||
61.0% | 0.036 | Caucasian | 494/890 (5) | 0.98[0.63~1.51] | 0.918 | 0.918 | ||
46.6% | 0.051 | PB | 1143/1436 (10) | 0.91[0.68~1.22] | 0.523 | 0.524 | ||
50.4% | 0.133 | China | 776/682 (3) | 0.97[0.58~1.63] | 0.915 | 0.974 | ||
73.1% | 0.024 | Turkey | 206/256 (3) | 1.26 [0.53~2.99] | 0.593 | 0.824 | ||
15.7% | 0.299 | PHWE > 0.05 | 1383/1675 (10) | 0.85[0.69~1.06] | 0.155 | 0.386 | ||
56.3% | 0.033 | PCR-RFLP | 601/827 (7) | 0.88 [0.61~1.28] | 0.988 | 0.988 | ||
TC + CC vs. TT | R | 50.7% | 0.027 | overall | 1485/1777 (11) | 0.94[0.71~1.23] | 0.636 | 0.690 |
56.0% | 0.059 | Asian | 941/837 (5) | 0.90[0.57~1.44] | 0.671 | 0.798 | ||
61.4% | 0.035 | Caucasian | 494/890 (5) | 0.93[0.62~1.40] | 0.733 | 0.880 | ||
49.6% | 0.037 | PB | 1143/1436 (10) | 0.90 [0.67~1.19] | 0.453 | 0.524 | ||
51.4% | 0.128 | China | 776/682 (3) | 0.99[0.59~1.66] | 0.974 | 0.974 | ||
76.8% | 0.013 | Turkey | 206/256 (3) | 1.12 [0.47~2.68] | 0.794 | 0.824 | ||
32.9% | 0.145 | PHWE > 0.05 | 1383/1675 (10) | 0.86[0.67~1.09] | 0.205 | 0.386 | ||
61.7% | 0.016 | PCR-RFLP | 601/827 (7) | 0.96 [0.63~1.45] | 0.843 | 0.988 | ||
CC vs. TT + TC | F | 4.4% | 0.398 | overall | 1325/1508 (9) | 0.91[0.69~1.20] | 0.487 | 0.690 |
0.0% | 0.506 | Asian | 781/568 (3) | 0.85[0.26~2.85] | 0.798 | 0.798 | ||
25.0% | 0.254 | Caucasian | 494/890 (5) | 0.86[0.64~1.16] | 0.330 | 0.629 | ||
10.9% | 0.345 | PB | 983/1167 (8) | 0.90[0.68~1.19] | 0.442 | 0.524 | ||
0.0% | 0.543 | China | 666/499 (2) | 1.30[0.29~5.76] | 0.734 | 0.974 | ||
47.7% | 0.148 | Turkey | 206/256 (3) | 0.81 [0.52~1.27] | 0.361 | 0.824 | ||
16.3% | 0.301 | PHWE > 0.05 | 1223/1406 (8) | 0.89[0.64~1.23] | 0.472 | 0.472 | ||
27.6% | 0.228 | PCR-RFLP | 551/741 (6) | 0.82 [0.59~1.14] | 0.228 | 0.744 | ||
carrier C vs. T | F | 1.1% | 0.430 | overall | 1485/1777 (11) | 0.93[0.80~1.09] | 0.380 | 0.690 |
41.4% | 0.145 | Asian | 941/837 (5) | 0.92[0.68~1.23] | 0.558 | 0.798 | ||
0.0% | 0.617 | Caucasian | 494/890 (5) | 0.92[0.76~1.11] | 0.388 | 0.629 | ||
0.0% | 0.492 | PB | 1143/1436 (10) | 0.90[0.77~1.06] | 0.223 | 0.524 | ||
37.9% | 0.200 | China | 776/682 (3) | 0.98[0.70~1.38] | 0.922 | 0.974 | ||
16.6% | 0.302 | Turkey | 206/256 (3) | 0.96[0.70~1.32] | 0.824 | 0.824 | ||
2.6% | 0.415 | PHWE > 0.05 | 1383/1675 (10) | 0.91[0.77~1.07] | 0.257 | 0.386 | ||
11.6% | 0.341 | PCR-RFLP | 601/827 (7) | 0.92 [0.75~1.11] | 0.372 | 0.744 |